Back
BridgeBio Pharma Quote, Financials, Valuation and Earnings
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here
Sell
46
BBIO
BridgeBio Pharma
Last Price:
27.03
Seasonality Move:
32.95%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.BridgeBio Pharma Price Quote
$27.03
+0.01 (+5.54%)
(Updated: May 2, 2024 at 3:56 AM ET)
BridgeBio Pharma Key Stats
Sell
46
BridgeBio Pharma (BBIO)
is a Sell
Day range:
$25.83 - $28.20
52-week range:
$12.75 - $44.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
472.68
P/B ratio:
0%
Volume:
2M
Avg. volume:
1.5M
1-year change:
88.42%
Market cap:
$4.8B
Revenue:
$9.3M
EPS:
$-3.94
How Much Does BridgeBio Pharma Make?
-
How Much Are BridgeBio Pharma's Sales Annually?
BBIO Revenues are $9.3M -
How Much Profit Does BridgeBio Pharma's Make A Year?
BBIO net income is -$643.2M
Is BridgeBio Pharma Growing As A Company?
-
What Is BridgeBio Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.07% -
What Is BridgeBio Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BridgeBio Pharma Stock Price Performance
-
Did BridgeBio Pharma Stock Go Up Last Month?
BridgeBio Pharma share price went down by -9.87% last month -
Did BBIO's Share Price Rise Over The Last Year?
BBIO share price rose by 88.42% over the past 1 year
What Is BridgeBio Pharma 52-Week High & Low?
-
What Is BridgeBio Pharma’s 52-Week High Share Price?
BridgeBio Pharma has traded as high as $44.32 over the past 52 weeks -
What Is BridgeBio Pharma’s 52-Week Low Share Price?
BridgeBio Pharma has traded as low as $12.75 over the past 52 weeks
BridgeBio Pharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy BridgeBio Pharma?
-
How Much Debt Does BridgeBio Pharma Have?
Total long term debt quarterly is $1.7B -
How Much Cash Does BridgeBio Pharma Have?
Cash and short term investments quarterly total is $434.9M -
What Is BridgeBio Pharma’s Book Value Per Share?
Book value per share is -7.73
Is BridgeBio Pharma Cash Flow Positive?
-
What Is BBIO Cash Flow From Operations?
Cash flow from operations (TTM) is -$527.7M -
What Is BridgeBio Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $451.5M -
What Is BridgeBio Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $54M
BridgeBio Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
BBIO return on invested capital is -143.37% -
What Is BridgeBio Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -108.88% -
What Is BBIO Return On Equity?
ROE is a measure of profitability and is 0%
BridgeBio Pharma Earnings Date & Stock Price
-
What Is BridgeBio Pharma's Stock Price Today?
A single share of BBIO can be purchased today for 27.02 -
What Is BridgeBio Pharma’s Stock Symbol?
BridgeBio Pharma trades on the nasdaq under the ticker symbol: BBIO -
When Is BridgeBio Pharma’s Next Earnings Date?
The next quarterly earnings date for BridgeBio Pharma is scheduled on May 3, 2024 -
When Is BBIO's next ex-dividend date?
BridgeBio Pharma's next ex-dividend date is May 2, 2024 -
How To Buy BridgeBio Pharma Stock?
You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BridgeBio Pharma Competitors
-
Who Are BridgeBio Pharma's Competitors?
Below is a list of companies who compete with BridgeBio Pharma or are related in some way:
BridgeBio Pharma Dividend Yield
Data Unavailable
BridgeBio Pharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -20.13% |
| Revenue: | -6.69% | -53.96% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 50.75 |
| Upside from Last Price: | 87.82% |